ATE489634T1 - In vitro methode zur klinischen diagnose. - Google Patents

In vitro methode zur klinischen diagnose.

Info

Publication number
ATE489634T1
ATE489634T1 AT03758834T AT03758834T ATE489634T1 AT E489634 T1 ATE489634 T1 AT E489634T1 AT 03758834 T AT03758834 T AT 03758834T AT 03758834 T AT03758834 T AT 03758834T AT E489634 T1 ATE489634 T1 AT E489634T1
Authority
AT
Austria
Prior art keywords
plasma protein
drug
binding
clinical diagnosis
binding site
Prior art date
Application number
AT03758834T
Other languages
English (en)
Inventor
Keiichi Kawai
Norito Takamura
Original Assignee
Nihon Mediphysics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Mediphysics Co Ltd filed Critical Nihon Mediphysics Co Ltd
Application granted granted Critical
Publication of ATE489634T1 publication Critical patent/ATE489634T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745Assays involving non-enzymic blood coagulation factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/76Assays involving albumins other than in routine use for blocking surfaces or for anchoring haptens during immunisation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/20Screening for compounds of potential therapeutic value cell-free systems

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT03758834T 2002-10-31 2003-10-23 In vitro methode zur klinischen diagnose. ATE489634T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002317568 2002-10-31
PCT/JP2003/013572 WO2004040309A1 (ja) 2002-10-31 2003-10-23 薬物の血漿蛋白結合における血漿蛋白質上の結合部位の測定法及び血漿蛋白質変異の測定法

Publications (1)

Publication Number Publication Date
ATE489634T1 true ATE489634T1 (de) 2010-12-15

Family

ID=32211729

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03758834T ATE489634T1 (de) 2002-10-31 2003-10-23 In vitro methode zur klinischen diagnose.

Country Status (9)

Country Link
US (1) US7175991B2 (de)
EP (1) EP1557671B1 (de)
JP (1) JP4236050B2 (de)
AT (1) ATE489634T1 (de)
AU (1) AU2003275621A1 (de)
CA (1) CA2500866C (de)
DE (1) DE60335133D1 (de)
TW (1) TWI330714B (de)
WO (1) WO2004040309A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0203548D0 (sv) 2002-12-02 2002-12-02 Biacore Ab Method of determining site-specificity and kit therefor
JP5828507B2 (ja) * 2011-09-07 2015-12-09 国立大学法人金沢大学 尿検査方法及び尿検査用キット
CN114965981B (zh) * 2022-03-01 2025-06-06 上海健耕医药科技股份有限公司 胶乳增强免疫比浊法检测丙戊酸的试剂r1、试剂盒及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000078352A1 (en) * 1999-06-21 2000-12-28 Nihon Medi-Physics Co., Ltd. Method of the administration of drugs having binding affinity with plasma protein and preparation to be used in the method
JP4628568B2 (ja) 2001-03-13 2011-02-09 株式会社小松製作所 油圧モータによる変速装置

Also Published As

Publication number Publication date
US20060166269A1 (en) 2006-07-27
WO2004040309A1 (ja) 2004-05-13
JPWO2004040309A1 (ja) 2006-03-02
AU2003275621A1 (en) 2004-05-25
US7175991B2 (en) 2007-02-13
CA2500866A1 (en) 2004-05-13
EP1557671A4 (de) 2007-05-09
EP1557671A1 (de) 2005-07-27
DE60335133D1 (de) 2011-01-05
CA2500866C (en) 2013-06-25
TW200502551A (en) 2005-01-16
EP1557671B1 (de) 2010-11-24
JP4236050B2 (ja) 2009-03-11
TWI330714B (en) 2010-09-21

Similar Documents

Publication Publication Date Title
ATE466276T1 (de) Faseroptische vorrichtung zur wahrnehmung von analyten
DE60223668D1 (de) Kit zur messung von blutzuckerkonzentrationen
DE602005026898D1 (de) Manschette zur Blutdruckmessung und Blutdruckmessgerät mit der selben
EP1912674A4 (de) Bispezifische einzelketten-fv-antikörper-moleküle und anwendungsverfahren dafür
ATE440536T1 (de) Verfahren zur diagnose, behandlung und prävention von knochenverlust
ATE540319T1 (de) Verfahren für die bestimmung von fk506
WO2004046729A3 (en) Bodily fluid markers of tissue hypoxia
DE10292329D2 (de) Werkzeuge zur Diagnostik, molekularen Definition und Therapieentwicklung chronischer entzündlicher Gelenkerkrankungen
ATE435657T1 (de) Therapeutische zubereitung von hochreinem fviia und verfahren zu dessen gewinnung
WO2007080597A3 (en) Polynucleotide and polypeptide sequences and methods for diagnosis
EP1838867A4 (de) Apolipoprotein-a-ii-isoform als biomarker für prostatakrebs
CA2510377A1 (en) Use of nicotinamide n-methyltransferase as a marker for colorectal cancer
WO2007000320A3 (de) Verfahren zur diagnose von rheumatischen erkrankungen
BRPI0206904B8 (pt) métodos de quantificação de proteína glicada em uma amostra, de quantificação da quantidade de proteína glicada em uma amostra biológica, de quantificação da hemoglobina glicada em uma amostra de sangue, e de quantificação de proteína glicada que não é hemoglobina em uma amostra biológica
EP1572225A4 (de) Thrombospondinfragmente und deren verwendung bei klinischen krebs-tests und der erzeugung von antikörpern und sonstigen bindungsmitteln
ATE426675T1 (de) Differenzialdiagnostik mit hepcidin
ATE489634T1 (de) In vitro methode zur klinischen diagnose.
DE50212280D1 (de) Verwendung von hmgb-proteinen und dafür codierenden nukleinsäuren
NO20076119L (no) Diagnostisk markor for diabetiske vaskulaere komplikasjoner
WO2006124866A3 (en) Free human serum ige immunoenzymetric assay and methods of use
WO2004019045A3 (en) Method for the diagnosis of alzheimer disease
BR0317404A (pt) Variantes do fator xiia
ATE472611T1 (de) Verfahren zur diagnose von sepsis durch analyse von cytokine mrna expression
DE502004000227D1 (de) Endoskop für medizinische und nicht-medizinische zwecke
ATE501276T1 (de) Verfahren zur gliomdiagnose mit unterscheidung zwischen progressiven und de-novo-formen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties